If you or a loved one has been diagnosed with uterine (endometrial) cancer, you may hear your care team mention “biomarker testing,” “molecular profiling,” or terms like MMR deficiency, MSI-high, p53 abnormalities, or POLE mutations. While these terms can sound technical, they are becoming an important part of how doctors personalize treatment for uterine (endometrial) […]

Uterine cancer is the most common gynecologic cancer in the United States. Unlike some cancers that develop silently, uterine cancer tends to produce noticeable warning signs (such as abnormal bleeding), which means the path to diagnosis often begins the moment something feels wrong. But noticing a symptom and getting a confirmed diagnosis are two very […]

When someone hears the words “uterine cancer,” it can sound like a single disease. But in reality, uterine cancer is not just one type of cancer. There are two main types: endometrial cancer and uterine sarcoma. While both begin in the uterus, they are very different in how they develop, how they are treated, and […]

Endometrial (uterine) cancer is most common after menopause, but diagnoses in younger women are rising, and women under 50 are now one of the fastest-growing groups being diagnosed. Over the past two decades, rates in this age group have steadily increased, even as awareness has lagged behind. It’s still not the typical patient, but it’s […]

A diagnosis of a gynecologic cancer, including endometrial (uterine), ovarian, cervical, vulvar, or vaginal cancer, can bring physical changes that are hard to manage. Surgery, chemotherapy, radiation, and hormone therapy can affect the pelvic area in ways that interfere with everyday comfort, mobility, bladder and bowel function, and intimacy. Pelvic floor therapy is one supportive […]